Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin

The aim of this study was to characterize the treatment response and tolerability of sofosbuvir plus ribavirin therapies in Japanese patients infected with hepatitis C virus (HCV) genotype (GT)-2. This retrospective study analyzed 114 Japanese HCV GT-2 patients treated for 12 weeks with 400 mg of so...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biology (Basel)
Asıl Yazarlar: Kanda, Tatsuo, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Tawada, Akinobu, Suzuki, Eiichiro, Ooka, Yoshihiko, Takahashi, Koji, Sasaki, Reina, Wu, Shuang, Nakamoto, Shingo, Arai, Makoto, Imazeki, Fumio, Yokosuka, Osamu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485477/
https://ncbi.nlm.nih.gov/pubmed/28486403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology6020030
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller